Literature DB >> 27867645

Management of screening-detected stage I lung cancer.

Raymond U Osarogiagbon1.   

Abstract

Entities:  

Year:  2016        PMID： 27867645      PMCID： PMC5107480          DOI： 10.21037/jtd.2016.10.78

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  25 in total

1.  Editorial preface to this special issue "Improving the quality and outcomes of lung cancer care: an interdisciplinary approach".

Authors:  Raymond U Osarogiagbon
Journal:  Transl Lung Cancer Res       Date:  2015-08

2.  Delays in diagnosis and treatment of lung cancer: Lessons from US healthcare settings.

Authors:  M M Koo; Y Zhou; G Lyratzopoulos
Journal:  Cancer Epidemiol       Date:  2015-09-09       Impact factor: 2.984

3.  Patterns of surgical care of lung cancer patients.

Authors:  Alex G Little; Valerie W Rusch; James A Bonner; Laurie E Gaspar; Mark R Green; W Richard Webb; Andrew K Stewart
Journal:  Ann Thorac Surg       Date:  2005-12       Impact factor: 4.330

4.  Mediastinal lymph node examination and survival in resected early-stage non-small-cell lung cancer in the surveillance, epidemiology, and end results database.

Authors:  Raymond U Osarogiagbon; Xinhua Yu
Journal:  J Thorac Oncol       Date:  2012-12       Impact factor: 15.609

5.  Computed Tomography Screening for Lung Cancer: Mediastinal Lymph Node Resection in Stage IA Nonsmall Cell Lung Cancer Manifesting as Subsolid and Solid Nodules.

Authors:  Raja M Flores; Daniel Nicastri; Thomas Bauer; Ralph Aye; Shahriyour Andaz; Leslie Kohman; Barry Sheppard; William Mayfield; Richard Thurer; Robert Korst; Michaela Straznicka; Fred Grannis; Harvey Pass; Cliff Connery; Rowena Yip; James P Smith; David F Yankelevitz; Claudia I Henschke; Nasser K Altorki
Journal:  Ann Surg       Date:  2017-05       Impact factor: 12.969

6.  Early Lung Cancer Action Project: overall design and findings from baseline screening.

Authors:  C I Henschke; D I McCauley; D F Yankelevitz; D P Naidich; G McGuinness; O S Miettinen; D M Libby; M W Pasmantier; J Koizumi; N K Altorki; J P Smith
Journal:  Lancet       Date:  1999-07-10       Impact factor: 79.321

7.  Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer.

Authors:  Michelle S Ludwig; Michael Goodman; Daniel L Miller; Peter A S Johnstone
Journal:  Chest       Date:  2005-09       Impact factor: 9.410

8.  Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non-Small Cell Lung Cancer.

Authors:  Matthew P Smeltzer; Nicholas Faris; Xinhua Yu; Robert A Ramirez; Laura E M Ramirez; Christopher G Wang; Courtney Adair; Allen Berry; Raymond U Osarogiagbon
Journal:  Ann Thorac Surg       Date:  2016-06-03       Impact factor: 4.330

9.  Survival Implications of Variation in the Thoroughness of Pathologic Lymph Node Examination in American College of Surgeons Oncology Group Z0030 (Alliance).

Authors:  Raymond U Osarogiagbon; Paul A Decker; Karla Ballman; Dennis Wigle; Mark S Allen; Gail E Darling
Journal:  Ann Thorac Surg       Date:  2016-06-02       Impact factor: 4.330

10.  Effect of delays on prognosis in patients with non-small cell lung cancer.

Authors:  G Myrdal; M Lambe; G Hillerdal; K Lamberg; Th Agustsson; E Ståhle
Journal:  Thorax       Date:  2004-01       Impact factor: 9.139
View more
  2 in total

1.  Should a therapeutic strategy be based on how the disease was diagnosed?

Authors:  Masaaki Sato
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

2.  Association between time-to-treatment and outcomes in non-small cell lung cancer: a systematic review.

Authors:  Helen Hall; Adam Tocock; Sarah Burdett; David Fisher; William M Ricketts; John Robson; Thomas Round; Sarita Gorolay; Emma MacArthur; Donna Chung; Sam M Janes; Michael D Peake; Neal Navani
Journal:  Thorax       Date:  2021-08-17       Impact factor: 9.102
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.